Inhibitors ofPARP-1(Poly(ADP-ribose)polymerase-1)act by competing with NAD+, the enzyme physiologicalsubstrate, which play a protective role in many pathological conditions characterized byPARP-1 overactivation. It has been shown thatPARP-1 also promotes tumor growth and progression through its DNA repair activity. Since angiogenesis is an essential requirement for these activities, wesought to determine whether PARP inhibition might affect rat brain microvascular endothelialcells(GP8.3) migration,stimulated by C6-glioma conditioned medium(CM).Through wound-healingexperiments and MTT analysis, we demonstrated thatPARP-1 inhibitorPJ-34[N-(6-Oxo-5,6-dihydro-phenanthridin-2-yl)-N,N-dimethylacetamide]abolishes the migratory response of GP8.3cells andreduces their viability.PARP-1 also acts in a DNA independent way with in the Extracellular-Regulated-Kinase(ERK)signaling cascade, which regulates cell proliferation and differentiation.Bywestern analysis and confocal laser scanning microscopy(LSM),we analyzed the effects of PJ-34 on PARP-1expression, phospho-ERK and phospho-Elk-1 activation.The effect of MEK(mitogen-activated-protein-kinase-kinase)inhibitor PD98059(2-(2-Amino-3-methoxyphenyl)-4H-1benzopyran-4-one)on PARP1 expression in unstimulated and in CM-stimulated GP8.3 cells was analyzed byRT-PCR.PARP-1expression and phospho-ERK activation were significantly reduced by treatment of GP8.3 cells withPJ-34 orPD98059.By LSM, we further demonstrated that PARP1 and phospho-ERK are coexpressed and share the same subcellular localization in GP8.3 cells, in the cytoplasmas well as innucleoplasm. Based on these data,wep roposet hatPARP-1 andp hospho-ERK interact in the cytosol and then translocate to the nucleus, where they trigger a proliferative response. We also propose that PARP-1 inhibition blocks CM-induced endothelial migration by interfering with ERKsignal-transduction pathway.

PJ-34 inhibits PARP-1 expression and ERK phosphorylation in glioma-conditioned brain microvascular endothelial cells.

MOTTA, CARLA;D’Angeli F;Scalia M;Satriano C;Barbagallo D;NALETOVA, IRINA;Anfuso CD;Lupo G;Spina V
2015

Abstract

Inhibitors ofPARP-1(Poly(ADP-ribose)polymerase-1)act by competing with NAD+, the enzyme physiologicalsubstrate, which play a protective role in many pathological conditions characterized byPARP-1 overactivation. It has been shown thatPARP-1 also promotes tumor growth and progression through its DNA repair activity. Since angiogenesis is an essential requirement for these activities, wesought to determine whether PARP inhibition might affect rat brain microvascular endothelialcells(GP8.3) migration,stimulated by C6-glioma conditioned medium(CM).Through wound-healingexperiments and MTT analysis, we demonstrated thatPARP-1 inhibitorPJ-34[N-(6-Oxo-5,6-dihydro-phenanthridin-2-yl)-N,N-dimethylacetamide]abolishes the migratory response of GP8.3cells andreduces their viability.PARP-1 also acts in a DNA independent way with in the Extracellular-Regulated-Kinase(ERK)signaling cascade, which regulates cell proliferation and differentiation.Bywestern analysis and confocal laser scanning microscopy(LSM),we analyzed the effects of PJ-34 on PARP-1expression, phospho-ERK and phospho-Elk-1 activation.The effect of MEK(mitogen-activated-protein-kinase-kinase)inhibitor PD98059(2-(2-Amino-3-methoxyphenyl)-4H-1benzopyran-4-one)on PARP1 expression in unstimulated and in CM-stimulated GP8.3 cells was analyzed byRT-PCR.PARP-1expression and phospho-ERK activation were significantly reduced by treatment of GP8.3 cells withPJ-34 orPD98059.By LSM, we further demonstrated that PARP1 and phospho-ERK are coexpressed and share the same subcellular localization in GP8.3 cells, in the cytoplasmas well as innucleoplasm. Based on these data,wep roposet hatPARP-1 andp hospho-ERK interact in the cytosol and then translocate to the nucleus, where they trigger a proliferative response. We also propose that PARP-1 inhibition blocks CM-induced endothelial migration by interfering with ERKsignal-transduction pathway.
PARP-1; phospho-ERK; PJ-34
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/20.500.11769/33566
Citazioni
  • ???jsp.display-item.citation.pmc??? 12
  • Scopus 16
  • ???jsp.display-item.citation.isi??? 16
social impact